Dr. Matthew P. Holtzman

Amer H. Zureikat, MD, is vice chair of surgery for surgical oncology in the Department of Surgery at UPMC, chief of Surgical Oncology at UPMC Hillman Cancer Center, and UPMC Chair of Clinical Surgery. He is the division chief for gastrointestinal surgical oncology in the Department of Surgery at UPMC and professor of surgery at the University of Pittsburgh School of Medicine. Dr. Zureikat specializes in cancers and diseases of the pancreas, stomach, liver and duodenum and is an expert in robotic pancreatic surgery. His clinical and academic interests include the multimodality treatment of pancreatic cancer, and comparative effectiveness of open and robotic approaches to gastrointestinal cancers in general and pancreatic cancer in particular.Dr. Zureikat is board-certified in general surgery. He received his medical degree from the Royal College of Surgeons in Dublin, Ireland, completed his general surgery residency at the University of Chicago Medical Center and his fellowship in surgical oncology at the University of Pittsburgh/UPMC. Dr. Zureikat is a member of the Society of University Surgeons (SUS), Society of Surgical Oncology (SSO), and the Americas Hepato-Pancreato-Biliary Association (AHPBA). In addition, he is a fellow of the American College of Surgeons (ACS). Dr. Zureikat is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Zureikat is board certified in American Board Of Surgery. Dr. Zureikat is currently accepting new patients.

Linwah Yip, MD, FACS, is an associate professor in the Department of Surgery, Division of Endocrine Surgery at the University of Pittsburgh School of Medicine, chief of the Division of Breast and Endocrine Surgery, and program director for the University of Pittsburgh  Endocrine Surgery Fellowship. She specializes in thyroid and parathyroid disease/cancers, adrenal tumors, and functional pancreatic tumors. She studies how molecular testing can optimize diagnosis and treatment for thyroid cancer patients and leads the UPMC VHL Alliance Comprehensive Clinical Care Center.Dr. Yip is board-certified in general surgery. She received her medical degree from the University of Chicago Pritzker School of Medicine, Chicago. Dr. Yip completed surgical residency training at Northwestern University in Chicago and the University of Florida Health Sciences Center in Jacksonville, Fla., and surgical oncology research and clinical fellowships at the University of Texas MD Anderson Cancer Center and UPMC. Dr. Yip is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Thyroid Nodule, Thyroid Cancer, Papillary Thyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Yip is board certified in American Board Of Surgery. Dr. Yip is currently accepting new patients.

Dr. Geller is a Professor of Surgery at the University of Pittsburgh School of Medicine, and Director of the UPMC Liver Cancer Center. As a hepatobiliary and liver transplant surgeon at the Starzl Transplant Institute, his clinical interests center on the evaluation and management of patients with liver cancers. He is focusing on novel and minimally invasive approaches for the treatment of liver cancer. He has particular operative expertise in performing laparoscopic liver resections and laparoscopic radiofrequency ablations of liver tumors. Dr. Geller is a member of many professional and scientific societies including the Society of Surgical Oncology, Society of University Surgeons, and the American Society of Transplant Surgeons. Dr. Geller is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Fibrolamellar Carcinoma, Hepatectomy, and Hepato-Pancreato-Biliary Surgery. Dr. Geller is board certified in American Board Of Surgery. Dr. Geller is currently accepting new patients.